Kyung Nam Pharm Co.,Ltd. (KOSDAQ: 053950)
South Korea
· Delayed Price · Currency is KRW
763.00
-1.00 (-0.13%)
Jan 22, 2025, 3:00 PM KST
Kyung Nam Pharm Co.,Ltd. Revenue
Kyung Nam Pharm Co.,Ltd. had revenue of 14.34B KRW in the quarter ending September 30, 2024, with 2.43% growth. This brings the company's revenue in the last twelve months to 69.43B, up 18.88% year-over-year. In the year 2023, Kyung Nam Pharm Co.,Ltd. had annual revenue of 68.45B with 16.01% growth.
Revenue (ttm)
69.43B
Revenue Growth
+18.88%
P/S Ratio
0.39
Revenue / Employee
303.20M
Employees
229
Market Cap
59.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 68.45B | 9.44B | 16.01% |
Dec 31, 2022 | 59.00B | -5.62B | -8.70% |
Dec 31, 2021 | 64.62B | -6.31B | -8.89% |
Dec 31, 2020 | 70.93B | 26.13B | 58.31% |
Dec 31, 2019 | 44.81B | 3.37B | 8.14% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |